December 10th & 11th, 2026
15th edition
MARSEILLE, FR
Stand D4

2016 Edition

Admescope

Finlande

Admescope is a CRO providing the pharmaceutical industry with tailor-made services to drug discovery in the area of ADME-Tox. The service offering is widely spread from highly tailored studies to High Throughput Screening (HTS). Our unique top-notch expertise lies in in vitro & in vivo drug metabolism; including metabolite profiling & identification, drug-drug interactions and quantitative bioanalysis. The right study assay can always be found whether in the discovery or lead optimisation phase.

Scroll to Top

Before you leave…

Download the official BioFIT 2026 brochure

Discover the conference programme, partnership opportunities, attendee profiles, registration options and everything you need to make the most of BioFIT 2026.